Mercy Medical Center Credited with High Performance in Lung Cancer Surgery

SPRINGFIELD — Mercy Medical Center has been rated ‘high performing’ in lung cancer surgery in the Springfield Metro area by U.S. News & World Report, as reported in the publication’s annual “Best Hospitals 2025-2026” ratings, which evaluate hospitals nationwide on 22 widely performed procedures and conditions.

“At Mercy Medical Center, patients benefit from our commitment to a comprehensive lung cancer program that includes lung cancer screening, interventional pulmonology, and robotic thoracic surgery, all delivered with a focus on clinical quality and patient safety. We are proud to be recognized by U.S. News & World Report for excellence in lung cancer surgery,” said Dr. Robert Roose, president of Community Hospitals for Trinity Health Of New England.

A hospital’s lung cancer surgery score is based on data such as patient survival rates, recovery at home, number of patients treated, cancer specific hospital accreditation, and more. About 4,500 hospitals were evaluated, and eligible hospitals received one of three ratings: high performing, as expected, or evaluated. Hospitals that earned a high performing rating typically have better patient outcomes compared to other hospitals.

Dr. Laki Rousou serves as chief of Thoracic Surgery, chief of Robotic Surgery, and medical director of the Lung Cancer Screening Program at Mercy Medical Center. In 2024, he completed his 1000th da Vinci robotic thoracic surgery using the da Vinci Xi surgical system, placing him among the nation’s most frequent users of the da Vinci surgical system for thoracic surgery. He is also a member of the Society of Thoracic Surgeons and the Massachusetts Medical Society. In 2018, Rousou was recognized as a LUNG FORCE Hero by the American Lung Assoc.